EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease

Sarah Mosca iD, Grazia Bottillo iD, Enrica Flori iD, Daniela Kovacs, Miriam Maiellaro iD, Francesca Lozzi, Alessia Cavallo iD, Christos C Zouboulis iD, Giulia Simmini, Alessia Luppino, Claudia Novello iD, Valentina Leta und 7 weitere

Cells · 2026

DOI: 10.3390/cells15161505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Sarah Mosca und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, It…. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Sebaceous Glands, Lipid Metabolism. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health, National Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological aggregation of α-synuclein (αSyn) is a hallmark of Parkinson’s disease (PD), but increasing evidence indicates that αSyn deposits extend beyond the central nervous system to peripheral tissues, including the skin. In PD patients, cutaneous αSyn accumulation has been associated with seborrheic dermatitis (SD), a chronic inflammatory condition linked to sebocyte dysfunction and altered sebum production. Marked differences in sebum composition between PD patients and healthy controls have been described. We aimed to investigate whether pathological αSyn could contribute to dysregulated sebum production and composition by assessing key markers of sebocyte differentiation and lipogenesis in human sebaceous gland cells and skin biopsies from PD patients (n = 5) and matched controls (n = 5) without clinically recorded SD. O-αSyn exposure of immortalized sebaceous gland cells (SZ95) altered the transcriptional programs related to sebocyte differentiation, inflammation, metabolism, and lipogenesis. Consistently, protein markers of mid-to-late sebocyte differentiation were increased. Upregulation of PLIN2, together with elevated PPARγ, SREBP1, SCD1, and FADS2, indicated progression toward a mature and lipid-producing phenotype characterized by enhanced accumulation of neutral lipids within lipid droplets. Lipidomic profiling revealed remodeling of multiple lipid classes, with increases in triglycerides, ceramides, and selected phospholipids. Increased expression of PLIN2 and PPARγ was also observed in sebaceous glands from PD skin biopsies compared to controls. Collectively, our findings indicate that O-αSyn exposure is associated with molecular changes consistent with altered sebocyte differentiation and lipid remodeling. These results support a potential association between αSyn and lipid dysregulation in sebocytes and suggest that these cells may represent unrecognized peripheral targets of αSyn.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinSebaceous GlandsLipid MetabolismLipidsHumansCell DifferentiationSebumPhenotypeLipogenesisPerilipin-2FemaleAgedDermatitis, SeborrheicMaleCell LineMiddle AgedSkin

Stichwörter der Autor:innen

Parkinson’s diseaseneurodegenerationsebaceous glandsebocyteseborrheic dermatitisα-synuclein

Substanzen

alpha-SynucleinPerilipin-2LipidsPLIN2 protein, human

Autor:innen und Institutionen

  • Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
  • Department of Dermatology, Venereology and Immunology, Faculty of Health Sciences, Brandenburg Medical School Theodor Fontane, Universitaetsklinikum Ruppin-Brandenburg, 16816 Neuruppin, Germany.
  • Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
  • Dementia and Degenerative Diseases of CNS Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
  • Parkinson's and Movement Disorders Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
  • Department Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, 20122 Milan, Italy.

ORCID-Profile: Sarah Mosca, Grazia Bottillo, Enrica Flori, Miriam Maiellaro, Alessia Cavallo, Christos C Zouboulis, Claudia Novello, Grazia Devigili, Roberto Eleopra, Emanuela Camera, Giorgia Cardinali

Förderung

  • Ministero della Salute
  • Italian Ministry of Health
  • National Research Program

Zitieren

APA

Mosca, S., Bottillo, G., Flori, E., Kovacs, D., Maiellaro, M., Lozzi, F., Cavallo, A., Zouboulis, C. C., Simmini, G., Luppino, A., Novello, C., Leta, V., Gaudiano, G., Devigili, G., Eleopra, R., Tagliavini, F., Mazzetti, S., Camera, E., & Cardinali, G. (2026). Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease. Cells. https://doi.org/10.3390/cells15161505

Vancouver

Mosca S, Bottillo G, Flori E, Kovacs D, Maiellaro M, Lozzi F, et al. Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease. Cells. 2026. doi:10.3390/cells15161505

BibTeX
@article{Mosca2026,
  author = {Mosca, Sarah and Bottillo, Grazia and Flori, Enrica and Kovacs, Daniela and Maiellaro, Miriam and Lozzi, Francesca and Cavallo, Alessia and Zouboulis, Christos C and Simmini, Giulia and Luppino, Alessia and Novello, Claudia and Leta, Valentina and Gaudiano, Gianfranco and Devigili, Grazia and Eleopra, Roberto and Tagliavini, Fabrizio and Mazzetti, Samanta and Camera, Emanuela and Cardinali, Giorgia},
  title = {Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15161505}
}
Kostenlos starten →